We are excited to share that our publication on the performance characteristics of our automated planar microarray immunoassay for the detection of antibodies against Centromere Protein B is now available in Immunochemistry & Immunopathology:
Would you like to know more about our MosaiQ solution? Click below to learn more:
Our passion for the work we do is matched only by our commitment to consistently provide the best customer experience possible.
AliveDx is dedicated to expanding its reach and presence across diverse regions, with the goal of delivering both clinical and economical value to clinicians by reducing the time to diagnosis for patients suffering from autoimmune and allergy diseases. We are
We are delighted to speak at the upcoming International Friday Meeting on Friday, 6 December 2024 at 6:30AM CET. The International Friday Meeting is a monthly meeting, held on the first Friday of the month, hosted by Pr. Yehuda Shoenfeld.
AliveDx Suisse S.A. and Medikonia Limited have signed a distribution agreement, which will enable Medikonia to distribute the MosaiQ® solution in Hong Kong and Macau. The distribution agreement takes effect immediately. AliveDx is committed to broadening its reach and presence
We are proud to announce that we have become a member of BIVDA, the UK’s leading IVD industry association. BIVDA is the national industry association for manufacturers and distributors of medical diagnostic tests in the UK, representing 97% of the
AliveDx Suisse S.A. and Bio-State Inc. have signed a distribution agreement, which will enable Bio-State Inc. to distribute the MosaiQ® solution in India. The distribution agreement takes effect immediately. This strategic partnership with an important partner in India reaffirms AliveDx’s
Meet the Alba team at the AABB Annual Meeting to learn how our high-quality blood bank reagents can drive value in your lab! Sign up for a booth meeting with your Account Executive today.
